An underground economy for unlicensed weight-loss drugs is being driven by social media fitness personalities and sellers on communication apps, based on new investigations.
Investigational Drug Acquiring Popularity Online
The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Followers are encouraged to contact these profiles directly for supplier links, while also obtaining discount codes.
Thriving Commerce on Messaging Platforms
Additionally, a robust trade exists on Telegram, where communities with numerous of participants share “before and after” photos, injection guides and assertions of rapid UK delivery. Vendors market the drug there before directing customers to WhatsApp for purchases.
Understanding The Experimental Drug
Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.
Medical Professionals Voice Concerns
However, doctors and chemists have cautions that the distribution of what remains an unlicensed drug in the UK is a cause for concern and could result in individuals administering substances of unknown origin.
Several experts said the popularity for the experimental drug could be linked to the increasing cost of licensed slimming products such as Mounjaro.
Regulatory Position and Enforcement
Marketing the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that cannot be marketed or distributed for personal consumption under the British medical regulations.
Several influencers attempt to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still violate pharmaceutical, marketing, and consumer regulations, potentially leading to fines, legal action or imprisonment.
Platform Reaction and Content Removal
According to the social media company, the service has removed problematic content and prohibited associated keywords and search suggestions. The organization stated it was dedicated to maintaining the platform secure and allocating resources in strengthening enforcement strategies.
Online Trading Operations
Investigations also discovered communities with up to 9,000 participants marketing the experimental drug using the platform's built-in discovery tool, which functions like a public directory. Entering “retatrutide” immediately brings up channels with thousands of members, populated with photos of slimming results, positive reviews and step-by-step guides for mixing or administering at home.
Within minutes of entering one group, a seller shared contact information, where most transactions take place. The seller provided an guidebook and promised delivery within two days. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None asked about weight, medical conditions or past usage.
Item Information and Pricing
Inside these groups, messages show dark colored packages with postal service stickers, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, mixed at residence with sterile water, or pre-filled pens typically priced at 160 pounds for 20 milligrams. When asked how long a injector should last, vendors give contradictory answers ranging from a few weeks to “depends on your body”.
Platform Moderation and Safety Measures
A spokesperson for Telegram said it regularly monitored dangerous content on its service including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Expert Warnings
“People are injecting materials they can’t verify. Although the research behind retatrutide is valid, these digital versions may not contain what they advertise,” stated Jason Murphy, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to current cost increases for authorized slimming drugs such as Mounjaro. “With costs rising, patients are turning to social media. But fake injections are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she said.
Her staff has previously seen patients injured by self-injection from unverified sources. “We understand the frustration, but buying from messaging apps or WhatsApp is gambling with your health,” said the doctor. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Position
A spokesperson from the pharmaceutical company said the substance was in third stage clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this point no one can market [it] for personal consumption,” they said, adding that any product “misleadingly claiming itself as a company investigational product not yet authorized … may subject users to possibly serious health risks”.
